MedTrace Logo

The Safety and Performence of ShockPulse-10 in Patients with Coronary Artery Calcification

NCT06711822 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 205

Last updated 2024-12-02

No results posted yet for this study

Summary

This study is an exploratory, multicenter, single-group clinical trial aimed to evaluate the clinical outcomes of using ShockPulse-10 in the treatment of coronary artery calcification .

Conditions

  • Coronary Arterial Disease (CAD)
  • Calcification; Heart

Interventions

DEVICE

Shockplus-10

Patients with coronary artery calcification who are planned to undergo PCI and are deemed in need of ShockPulse-10 treatment by their physicians

Sponsors & Collaborators

  • Keya Medical

    lead INDUSTRY

Principal Investigators

  • XIANTAO SONG, Dortor · Beijing Anzhen Hosipital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-01
Primary Completion
2025-06-30
Completion
2025-12-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06711822 on ClinicalTrials.gov